Henry Schein, Inc. · NASDAQ (us_market)
Healthcare · Medical Distribution · United States
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-07-03$74.67 RISE2025-10-16$62.03 PEAK2026-01-08$79.00 189d | -16.9% 105d | Missed | Missed | — | — | +27.4% 84d | Missed |
DROP2025-02-05$81.91 RISE2025-04-08$62.70 PEAK2025-07-03$74.67 148d | -23.5% 62d | Missed | Missed | — | — | +19.1% 86d | Missed |
DROP2023-07-13$82.07 RISE2023-11-02$61.89 PEAK2023-12-28$76.06 168d | -24.6% 112d | Missed | Missed | — | — | +22.9% 56d | Missed |
DROP2022-06-07$85.34 RISE2022-10-12$65.74 PEAK2022-12-02$83.29 178d | -23.0% 127d | Missed | Missed | — | — | +26.7% 51d | Missed |
DROP2021-01-13$73.88 RISE2021-03-04$61.50 PEAK2021-05-10$82.97 117d | -16.8% 50d | Missed | Missed | — | — | +34.9% 67d | Missed |
DROP2020-08-03$70.90 RISE2020-09-23$57.18 PEAK2020-12-10$71.31 129d | -19.4% 51d | Missed | Missed | — | — | +24.7% 78d | Missed |
DROP2020-02-19$73.71 RISE2020-05-13$51.13 PEAK2020-08-03$70.90 166d | -30.6% 84d | 2020-03-20 $45.01 | 2020-08-03 $70.90 | 77Deep Value | 55Deep Value | +38.7% 82d | +57.5% Held 136d |
DROP2020-02-19$73.71 RISE2020-03-23$43.18 PEAK2020-06-08$66.96 110d | -41.4% 33d | 2020-03-20 $45.01 | 2020-06-08 $66.96 | 77Deep Value | 58Deep Value | +55.1% 77d | +48.8% Held 80d |
Henry Schein (NASDAQ:HSIC) executives said the company is on track with its 2026 commitments and value-creation plan, while pointing to continued momentum in the U.S. dental market despite broader concerns about consumer confidence. Speaking at a Stifel dental track event moderated by Stifel Managi
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 4.1% gain for healthcare stocks has fallen short of the S&P 500’s 10.3% rise.
Henry Schein is backed by a dental and medical distribution scale, digital dentistry push and acquisitions, but debt and macro headwinds weigh on its outlook.
MELVILLE, N.Y., May 22, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel as Independent Chairman of the Board, effective May 21, 2026. Mr. Daniel succeeds Stanley M. Bergman, who retired from the Board following 44 years as a Director of Henry Schein and was named Chairman Emeritus in recognition of his extraordinary contr
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William K. "Dan" Daniel
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Henry Schein (HSIC) is drawing fresh attention as investors reassess the stock after recent share price swings. The company’s mixed near term returns contrast with its longer term performance profile and current valuation metrics. See our latest analysis for Henry Schein. Recent share price swings reflect this tension, with a 7 day share price return of 5.44% after a weaker 30 day share price return of 7.48% and a 1 year total shareholder return of 1.60%. This suggests that momentum has been...
Henry Schein (HSIC) is drawing fresh attention as investors reassess the stock after recent share price swings. The company’s mixed near term returns contrast with its longer term performance profile and current valuation metrics. See our latest analysis for Henry Schein. Recent share price swings reflect this tension, with a 7 day share price return of 5.44% after a weaker 30 day share price return of 7.48% and a 1 year total shareholder return of 1.60%. This suggests that momentum has been...
Henry Schein has trailed the broader market over the past 52 weeks, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season. Speaking at a Bank of America h
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season. Speaking at a Bank of America h
Thermon Group delivers industrial heating solutions worldwide, serving sectors from energy and transit to tech and manufacturing.
Thermon Group delivers industrial heating solutions worldwide, serving sectors from energy and transit to tech and manufacturing.
This engineering and technology firm delivers mission-critical solutions to government and industrial clients worldwide.
This engineering and technology firm delivers mission-critical solutions to government and industrial clients worldwide.
Henry Schein’s first quarter results were well received by the market, with outperformance driven by robust gains in U.S. dental and global technology segments. CEO Frederick Lowery pointed to ongoing market share gains and stable dental procedure volumes as key contributors, while highlighting that merchandise price increases and continued investments from dental service organizations (DSOs) underpinned growth. The medical business was impacted by a lighter flu season, which weighed on demand f
Henry Schein’s first quarter results were well received by the market, with outperformance driven by robust gains in U.S. dental and global technology segments. CEO Frederick Lowery pointed to ongoing market share gains and stable dental procedure volumes as key contributors, while highlighting that merchandise price increases and continued investments from dental service organizations (DSOs) underpinned growth. The medical business was impacted by a lighter flu season, which weighed on demand f
AMERICAN FORK, Utah, May 14, 2026--Henry Schein One, the global leader in dental technology, today announced the release of its 2026 Catalyst Index, the fifth edition of its annual benchmarking report analyzing performance across tens of thousands of DSOs, multi-location organizations, and private practices.
Henry Schein, Inc. (HSIC) Bank of America Global Healthcare Conference 2026 May 13, 2026 5:20 PM EDTCompany ParticipantsFrederick Lowery - CEO &...
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| HSIC | +3.58% | -5.89% | +1.32% | +9.42% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +0.62% | -0.17% | +4.77% | -3.27% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| FidelityFMR | fundamental | 5.72M | $421.72M | 0.02% | Added+44.0% | 2026-03-31 |
| StateStreet | passive | 4.38M | $322.73M | 0.01% | Trimmed-0.5% | 2026-03-31 |
| Citadel | multi-strat | 520.1K | $38.33M | 0.05% | New | 2026-03-31 |
| Bridgewater | macro | 32.1K | $2.37M | 0.01% | Added+333.0% | 2026-03-31 |
| DEShaw | quant | 30.8K | $2.27M | 0.00% | Trimmed-67.4% | 2026-03-31 |
| Wellington | fundamental | 7.3K | $538.23K | 0.00% | Trimmed-5.7% | 2026-03-31 |
| TRowePrice | fundamental | 149.0K | $10.98K | 0.00% | Trimmed-1.7% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | BERGMAN STANLEY M | Director | G Gift | 50 | — | +$0 |
| 2026-05-21 | BERGMAN STANLEY M | Director | G Gift | 1,040 | — | +$0 |
| 2026-05-12 | DANIEL WILLIAM K | Director | P Open-market purchase | 10,000 | $69.19 | +$691.9K |
| 2026-03-20 | Popeck Thomas C | CEO, Henry Schein Products | S Open-market sale | 1,355 | $72.79 | −$98.6K |
| 2026-03-17 | Albertini Andrea | CEO, Global Dist. & Tech. | F Tax withholding | 1,401 | $74.61 | −$104.5K |
| 2026-03-17 | BERGMAN STANLEY M | Director | F Tax withholding | 50 | $74.61 | −$3.7K |
| 2026-03-17 | BERGMAN STANLEY M | Director | G Gift | 400 | — | +$0 |
| 2026-03-17 | Ettinger Michael S | EVP & Chief Operating Officer | G Gift | 1,000 | — | +$0 |
| 2026-03-17 | Ettinger Michael S | EVP & Chief Operating Officer | F Tax withholding | 4,214 | $74.61 | −$314.4K |
| 2026-03-17 | Ettinger Michael S | EVP & Chief Operating Officer | G Gift | 1,300 | — | +$0 |
| 2026-03-17 | MLOTEK MARK E | EVP, Chief Strategic Officer | F Tax withholding | 5,928 | $74.61 | −$442.3K |
| 2026-03-17 | Popeck Thomas C | CEO, Henry Schein Products | F Tax withholding | 587 | $74.61 | −$43.8K |
| 2026-03-17 | Sheehy Christine Zayac | SVP, Chief Human Res. Officer | F Tax withholding | 463 | $74.61 | −$34.5K |
| 2026-03-17 | South Ronald N. | SVP & Chief Financial Officer | F Tax withholding | 5,216 | $74.61 | −$389.2K |
| 2026-03-16 | BERGMAN STANLEY M | Director | G Gift | 970 | — | +$0 |
| 2026-03-11 | KUEHN KURT P | Director | S Open-market sale | 2,844 | $78.96 | −$224.6K |
| 2026-03-10 | Albertini Andrea | CEO, Global Dist. & Tech. | A Grant / award | 60,631 | — | +$0 |
| 2026-03-10 | Ettinger Michael S | EVP & Chief Operating Officer | A Grant / award | 27,061 | — | +$0 |
| 2026-03-10 | Lowery Frederick M. | CEO | A Grant / award(deriv) | 177,116 | — | +$0 |
| 2026-03-10 | Lowery Frederick M. | CEO | A Grant / award | 64,433 | — | +$0 |
| 2026-03-10 | MLOTEK MARK E | EVP, Chief Strategic Officer | A Grant / award | 27,061 | — | +$0 |
| 2026-03-10 | MLOTEK MARK E | EVP, Chief Strategic Officer | G Gift | 300 | — | +$0 |
| 2026-03-10 | Popeck Thomas C | CEO, Henry Schein Products | A Grant / award | 53,206 | — | +$0 |
| 2026-03-10 | Sheehy Christine Zayac | SVP, Chief Human Res. Officer | A Grant / award | 7,087 | — | +$0 |
| 2026-03-10 | South Ronald N. | SVP & Chief Financial Officer | A Grant / award | 20,296 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-04upcoming | 1.23 | — | — |
| 2026-05-05 | 1.22 | 1.32 | +8.44% |
| 2026-02-24 | 1.29 | 1.34 | +3.48% |
| 2025-11-04 | 1.28 | 1.38 | +7.89% |
| 2025-08-05 | 1.19 | 1.10 | -7.61% |
| 2025-05-05 | 0.90 | 0.88 | -2.64% |
| 2025-02-25 | 1.21 | 1.19 | -1.56% |
| 2024-11-05 | 1.17 | 1.22 | +4.49% |
| 2024-08-06 | 1.22 | 1.23 | +1.01% |
| 2024-05-07 | 1.01 | 1.10 | +8.56% |
| 2024-02-27 | 0.70 | 0.66 | -5.24% |
| 2023-11-13 | 1.32 | 1.32 | +0.19% |
| 2023-08-07 | 1.28 | 1.31 | +2.61% |
| 2023-05-09 | 1.23 | 1.21 | -1.86% |
| 2023-02-16 | 1.22 | 1.35 | +10.68% |
| 2022-11-01 | 1.14 | 1.15 | +1.27% |